Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avantor, Inc. stock logo
AVTR
Avantor
$13.03
-1.0%
$14.22
$11.82
$28.00
$8.96B1.097.94 million shs5.75 million shs
Camtek Ltd. stock logo
CAMT
Camtek
$65.28
-1.1%
$63.06
$47.41
$140.50
$2.98B1.36566,599 shs258,288 shs
Revvity, Inc. stock logo
RVTY
Revvity
$91.35
-1.0%
$95.69
$88.01
$129.50
$10.77B1.02953,657 shs1.10 million shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avantor, Inc. stock logo
AVTR
Avantor
+3.54%-2.45%+1.70%-23.64%-45.53%
Camtek Ltd. stock logo
CAMT
Camtek
+1.58%+0.36%-0.80%-16.62%-37.63%
Revvity, Inc. stock logo
RVTY
Revvity
+3.07%-1.25%-2.21%-19.81%-18.58%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avantor, Inc. stock logo
AVTR
Avantor
4.9664 of 5 stars
4.25.00.03.23.63.32.5
Camtek Ltd. stock logo
CAMT
Camtek
4.511 of 5 stars
4.53.02.50.03.02.51.9
Revvity, Inc. stock logo
RVTY
Revvity
3.7346 of 5 stars
4.42.01.70.02.71.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avantor, Inc. stock logo
AVTR
Avantor
2.46
Hold$18.8844.91% Upside
Camtek Ltd. stock logo
CAMT
Camtek
3.00
Buy$90.7839.06% Upside
Revvity, Inc. stock logo
RVTY
Revvity
2.80
Moderate Buy$125.6437.55% Upside

Current Analyst Ratings Breakdown

Latest CAMT, RVTY, and AVTR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2025
Camtek Ltd. stock logo
CAMT
Camtek
Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$105.00
5/14/2025
Camtek Ltd. stock logo
CAMT
Camtek
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$85.00 ➝ $95.00
5/14/2025
Camtek Ltd. stock logo
CAMT
Camtek
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$100.00 ➝ $82.00
5/14/2025
Camtek Ltd. stock logo
CAMT
Camtek
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$110.00 ➝ $80.00
5/1/2025
Revvity, Inc. stock logo
RVTY
Revvity
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$145.00 ➝ $115.00
4/29/2025
Avantor, Inc. stock logo
AVTR
Avantor
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight
4/29/2025
Avantor, Inc. stock logo
AVTR
Avantor
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$23.00 ➝ $14.00
4/29/2025
Revvity, Inc. stock logo
RVTY
Revvity
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$140.00 ➝ $125.00
4/29/2025
Revvity, Inc. stock logo
RVTY
Revvity
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$120.00 ➝ $100.00
4/29/2025
Revvity, Inc. stock logo
RVTY
Revvity
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$145.00 ➝ $120.00
4/29/2025
Revvity, Inc. stock logo
RVTY
Revvity
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$127.00 ➝ $125.00
(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avantor, Inc. stock logo
AVTR
Avantor
$6.69B1.33$1.21 per share10.76$8.75 per share1.49
Camtek Ltd. stock logo
CAMT
Camtek
$450.86M6.60$1.65 per share39.53$12.11 per share5.39
Revvity, Inc. stock logo
RVTY
Revvity
$2.77B3.89$6.78 per share13.47$63.00 per share1.45
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avantor, Inc. stock logo
AVTR
Avantor
$711.50M$1.0412.5210.851.5510.49%12.17%5.38%7/25/2025 (Estimated)
Camtek Ltd. stock logo
CAMT
Camtek
$118.51M$2.6126.9820.151.8927.61%24.99%14.81%7/30/2025 (Estimated)
Revvity, Inc. stock logo
RVTY
Revvity
$270.39M$2.3541.3316.433.829.81%7.68%4.62%8/4/2025 (Estimated)

Latest CAMT, RVTY, and AVTR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Camtek Ltd. stock logo
CAMT
Camtek
$0.77$0.79+$0.02$0.70$119.00 million$118.64 million
4/28/2025Q1 2025
Revvity, Inc. stock logo
RVTY
Revvity
$0.96$1.01+$0.05$0.35$662.30 million$664.76 million
4/25/2025Q1 2025
Avantor, Inc. stock logo
AVTR
Avantor
$0.23$0.23N/A$0.09$1.61 billion$1.58 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avantor, Inc. stock logo
AVTR
Avantor
N/AN/AN/AN/AN/A
Camtek Ltd. stock logo
CAMT
Camtek
$1.332.04%N/A50.96%N/A
Revvity, Inc. stock logo
RVTY
Revvity
$0.280.31%N/A11.91%N/A

Latest CAMT, RVTY, and AVTR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2025
Revvity, Inc. stock logo
RVTY
Revvity
quarterly$0.070.29%7/18/20257/18/20258/8/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avantor, Inc. stock logo
AVTR
Avantor
0.54
1.07
0.70
Camtek Ltd. stock logo
CAMT
Camtek
0.36
5.00
4.11
Revvity, Inc. stock logo
RVTY
Revvity
0.41
3.60
3.03

Institutional Ownership

CompanyInstitutional Ownership
Avantor, Inc. stock logo
AVTR
Avantor
95.08%
Camtek Ltd. stock logo
CAMT
Camtek
41.93%
Revvity, Inc. stock logo
RVTY
Revvity
86.65%

Insider Ownership

CompanyInsider Ownership
Avantor, Inc. stock logo
AVTR
Avantor
1.20%
Camtek Ltd. stock logo
CAMT
Camtek
79.40%
Revvity, Inc. stock logo
RVTY
Revvity
0.68%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avantor, Inc. stock logo
AVTR
Avantor
14,500681.43 million672.05 millionOptionable
Camtek Ltd. stock logo
CAMT
Camtek
40045.59 million9.35 millionOptionable
Revvity, Inc. stock logo
RVTY
Revvity
16,700117.87 million120.97 millionOptionable

Recent News About These Companies

Revvity (NYSE:RVTY) Stock Rating Lowered by Wall Street Zen
Revvity, Inc. stock logo
Revvity (NYSE:RVTY) Cut to "Hold" at Wall Street Zen
Zacks Research Forecasts Revvity's Q1 Earnings (NYSE:RVTY)
Zacks Research Has Negative Outlook for Revvity Q2 Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Avantor stock logo

Avantor NYSE:AVTR

$13.02 -0.13 (-0.95%)
Closing price 03:59 PM Eastern
Extended Trading
$13.09 +0.06 (+0.50%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Camtek stock logo

Camtek NASDAQ:CAMT

$65.28 -0.74 (-1.12%)
Closing price 04:00 PM Eastern
Extended Trading
$66.51 +1.23 (+1.88%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry. The company provides Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to address the challenges fanout wafer level packaging applications. It also develops automatic defect classification, which provides automatic defect classification of color images utilizing deep learning techniques to reduce and eliminate manual verification. In addition, the company offers MicroProf AP, a wafer metrology tool for applications at 3D packaging process steps; MicroProf DI, an optical inspection tool that enables inspection of structured and unstructured wafers for manufacturing process; MicroProf FE, a 2D/3D wafer metrology tool that serve front end HVM fab; MicroProf FS, an wafer metrology tool configurable for wafer foundry; MicroProf PT for hybrid metrology applications to common panel sizes; MicroProf MHU metrology tool, a material handling unit for semiconductor, MEMS, sapphire, and LED industries; MicroProf TL, an optical surface measurement tool for fully automatic 3D surface measurements; MicroProf 100, a universal surface metrology tool for determination of topography and film and sample thickness; MicroProf 200, a measuring device for contactless and non-destructive characterization of surfaces and films; and MicroProf 300, a SurfaceSens technology for quality assurance, development, and manufacturing. It serves semiconductor manufacturers, outsourced semiconductor assembly and test, integrated device manufacturers, and wafer level packaging subcontractors. Camtek Ltd. was incorporated in 1987 and is headquartered in Migdal Haemek, Israel.

Revvity stock logo

Revvity NYSE:RVTY

$91.35 -0.88 (-0.96%)
Closing price 03:59 PM Eastern
Extended Trading
$91.34 0.00 (0.00%)
As of 05:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.